Literature DB >> 8276756

Determination of carboxyl-terminal residue and disulfide bonds of MACIF (CD59), a glycosyl-phosphatidylinositol-anchored membrane protein.

Y Sugita1, Y Nakano, E Oda, K Noda, T Tobe, N H Miura, M Tomita.   

Abstract

MACIF (CD59) is a glycosyl-phosphatidylinositol (GPI)-anchored membrane glycoprotein which inhibits the formation of membrane attack complex of human complement. MACIF prepared from human erythrocyte membranes was digested with pronase. When the digest was subjected to two-phase partition with butanol and 0.1 N HCl, the carboxyl-terminal peptide was recovered in the butanol phase because of the attachment of the highly hydrophobic GPI. The amino acid sequence of the peptide was determined to be Asn72 at its amino-terminus and up to Glu76, while the presence of Asn77 was ambiguous. To allow unequivocal determination of the carboxyl-terminus, a soluble form of MACIF was prepared from human urine on a large scale. The carboxyl-terminal peptide from the soluble form was prepared by tryptic digestion followed by reversed-phase HPLC. The sequence and composition of the peptide unequivocally revealed Asn77 as the carboxyl-terminus. The pattern of disulfide bonds of MACIF was also determined with the membrane form as well as the soluble form. Cystine-containing peptides were prepared by chymotryptic and tryptic digestion, purified by HPLC, and their amino acid sequences were determined. The results indicated that disulfide bonds were formed at Cys3-Cys26, Cys6-Cys13, Cys19-Cys39, Cys45-Cys63 (or 64), and Cys63 (or 64)-Cys69.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8276756     DOI: 10.1093/oxfordjournals.jbchem.a124202

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

1.  Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site.

Authors:  N K Rushmere; R A Harrison; C W van den Berg; B P Morgan
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

2.  Identification of a novel short peptide seal specific to CD59 and its effect on HeLa cell growth and apoptosis.

Authors:  Bing Li; Mei-Hua Gao; Xian-Ming Chu; Ying-Jie Xu; Fan Yang
Journal:  Cell Oncol (Dordr)       Date:  2012-09-04       Impact factor: 6.730

3.  Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies.

Authors:  Timothy M Shaver; Brian D Lehmann; J Scott Beeler; Chung-I Li; Zhu Li; Hailing Jin; Thomas P Stricker; Yu Shyr; Jennifer A Pietenpol
Journal:  Cancer Res       Date:  2016-05-26       Impact factor: 12.701

4.  Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis.

Authors:  S Meri; T Lehto; C W Sutton; J Tyynelä; M Baumann
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

5.  Production and functional characterization of a soluble recombinant form of mouse CD59.

Authors:  N K Rushmere; C W Van Den Berg; B P Morgan
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

6.  Glycosylphosphatidylinositol lipid anchoring of plant proteins. Sensitive prediction from sequence- and genome-wide studies for Arabidopsis and rice.

Authors:  Birgit Eisenhaber; Michael Wildpaner; Carolyn J Schultz; Georg H H Borner; Paul Dupree; Frank Eisenhaber
Journal:  Plant Physiol       Date:  2003-12       Impact factor: 8.340

7.  Recombinant soluble CD59 inhibits reactive haemolysis with complement.

Authors:  Y Sugita; K Ito; K Shiozuka; H Suzuki; H Gushima; M Tomita; Y Masuho
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

8.  Overexpression of CD59 inhibits apoptosis of T-acute lymphoblastic leukemia via AKT/Notch1 signaling pathway.

Authors:  Yanfei Jia; Yan Qi; Yunshan Wang; Xiaoli Ma; Yihui Xu; Jun Wang; Xiaoqian Zhang; Meihua Gao; Beibei Cong; Shuyi Han
Journal:  Cancer Cell Int       Date:  2019-01-08       Impact factor: 5.722

9.  Inhibition of NADPH Oxidase-Derived Reactive Oxygen Species Decreases Expression of Inflammatory Cytokines in A549 Cells.

Authors:  Joanna Wieczfinska; Przemyslaw Sitarek; Ewa Skała; Tomasz Kowalczyk; Rafal Pawliczak
Journal:  Inflammation       Date:  2019-12       Impact factor: 4.657

10.  Discovery of novel Schistosoma japonicum antigens using a targeted protein microarray approach.

Authors:  Hamish E G McWilliam; Patrick Driguez; David Piedrafita; Donald P McManus; Els N T Meeusen
Journal:  Parasit Vectors       Date:  2014-06-25       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.